Novo Holdings Ab Cellera Biologics Inc. Transaction History
Novo Holdings
- $1.23 Billion
- Q4 2024
A detailed history of Novo Holdings transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Novo Holdings holds 1,126,915 shares of ABCL stock, worth $3.41 Million. This represents 0.27% of its overall portfolio holdings.
Number of Shares
1,126,915
Previous 1,126,915
-0.0%
Holding current value
$3.41 Million
Previous $2.92 Million
13.13%
% of portfolio
0.27%
Previous 0.2%
Shares
3 transactions
Others Institutions Holding ABCL
# of Institutions
166Shares Held
120MCall Options Held
233KPut Options Held
339K-
Baker Bros. Advisors LP New York, NY27.5MShares$83.4 Million0.89% of portfolio
-
Baillie Gifford & CO12.2MShares$37.1 Million0.03% of portfolio
-
Voya Investment Management LLC Atlanta, GA10.6MShares$32.2 Million0.04% of portfolio
-
Capital World Investors Los Angeles, CA7.93MShares$24 Million0.0% of portfolio
-
Prosight Management, LP Dallas, TX7.35MShares$22.3 Million6.4% of portfolio
About AbCellera Biologics Inc.
- Ticker ABCL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 285,139,008
- Market Cap $864M
- Description
- AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...